High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires

Annals of the Rheumatic Diseases

Volumn 72, Issue 5, 2013, Pages 736-740

  Haroon, Muhammad ^a   Kirby, Brian ^a   FitzGerald, Oliver ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FUMADERM; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; USTEKINUMAB;

ADULT; ARTHRITIS; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DERMATOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; PHOTOTHERAPY; POLYARTICULAR DISEASE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA SEVERITY INDEX; PSORIASIS EPIDEMIOLOGY SCREENING TOOL; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS SCREENING EVALUATION; QUESTIONNAIRE; RATING SCALE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; SKIN DISEASE; TORONTO PSORIATIC ARTHRITIS SCREENING;

ADULT; AGED; ARTHRITIS, PSORIATIC; DELAYED DIAGNOSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSORIASIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84875956855     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201706     Document Type: Article

References (17)

1. Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003;42:1460-8. (Pubitemid 37508919)
2. Gladman DD. Psoriatic arthritis. In: Gordon K, Ruderman E, eds. Psoriasis and psoriatic arthritis. Berlin: Springer-Verlag, 2005:57-65.
3. Ogdie A, Seminara N, Langan S, et al. The impact of psoriasis extent on prevalence of psoriatic arthritis. [abstract]. Arthritis Rheum 2011; 63(Suppl 10):782.
4. Gladman DD, Thavaneswaran A, Chandran V, et al. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis 2011;70:2152-4.
5. Gladman DD, Schentag CT, Tom BD, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009;68:497-501.
6. Dominguez PL, Husni ME, Holt EW, et al. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009;301:573-9.
7. Husni ME, Meyer KH, Cohen DS, et al. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007;57: 581-7. (Pubitemid 47384917)
8. Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epdemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 2009;27:469-74.
9. Marshall CL, Harrison PV, Bukhari M. Validation of a psoriatic arthritis screening questionnaire in rheumatology and dermatology outpatients. [Abstract]. Rheumatology 2010;49(Suppl 1):i48-59. doi: 10.1093/rheumatology/keq716.
10. Walsh J, Clegg DO, Duffin KC. Comparison of screening instruments for psoriatic arthritis in patients with psoriasis. [Abstract]. Arthritis Rheum 2011;63(Suppl 10):1307.
11. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
12. Reich K, Krüger K, Mössner R, et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009;160:1040-7.
13. Zachariae H, Zachariae R, Blomqvist K, et al. Quality of life and prevalence of arthritis reported by 5795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002;82:108-13. (Pubitemid 34596683)
14. Ash ZR, Tinazzi I, Gallego CC, et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis 2011. [Epub ahead of print].
15. Wilson FC, Icen M, Crowson CS, et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009;61:233-9.
16. McLeod BD. Site of psoriasis (scalp or intergluteal/perianal), >or=3 affected sites, and nail dystrophy predicted psoriatic arthritis in incident psoriasis. Evid Based Med 2009;14:185.
17. Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987;62:127-41. (Pubitemid 17042878)